Brief: BB Biotech Sees Portfolio Cos To Report Q4 Pipeline Progress
18/10/2019 06:10
Oct 18 (Reuters) - BB BIOTECH AG BION.S :
* EXPECTS PORTFOLIO COMPANIES TO REPORT SUBSTANTIAL PIPELINE
PROGRESS DURING Q4
Source text for Eikon: ID:nEQ3Zhsn0a
Further company coverage: BION.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM